The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue SUPPL. 1, 1998, Pages

  Filippi, Massimo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Clinical trials; Disability; Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetisation transfer imaging; Multiple sclerosis

Indexed keywords

CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; INFORMATION PROCESSING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; TIME;

BRAIN; CLINICAL TRIALS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; TIME FACTORS;

EID: 0031748181     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (81)

1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39: 6-16.
2. Filippi M, Miller DH. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis Curr Opin Neurol 1996;9:176-86.
3. Barkhof F, Filippi M, Miller DH, et al. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis. J Neurol 1997;244:76-84.
4. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging to monitor disease activity in multiple sclerosis. Ann Neurol 1992; 32:758-66.
5. Nauta JJP, Thompson AJ, Barkhof F, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs. J Neurol Sci 1994;122:6-14.
6. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann Neurol 1993;34: 661-9.
7. Rieckmann P, Albrecht M, Kitze B, et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995;37:82-8.
8. Hartung HP, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-93.
9. 2+ influx in patients with relapsing-remitting multiple sclerosis. Neurology 1996;46; 1416-21.
10. Rieckmann P, Altenhofen B, Riegel A, et al. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann Neurol 1997;41:326-33.
11. Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991;114:2437-50.
12. Barkhof F, Filippi M, van Waesberghe JH, et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 1997;49:1682-8.
13. Paty DW, Li DBK, Oger JJF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994;36:S95-6.
14. Thorpe JW, Halpin SF, MacManus DG, et al. A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 1994;36:388-92.
15. Yousry TA, Filippi M, Becker C, et al. Comparison of SE, FSE, fast-FLAIR and TGSE sequences in detecting multiple sclerosis lesions. AJNR Am J Neuroradiol 1997; 18:959-63.
16. Bastianello S, Bozzao A, Paolillo A, et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol 1997; 18:699-704.
17. Filippi M, Bastianello S, Gasperini C, et al. A comparison of CSE, fast FLAIR and enhanced T1-weighted MRI scans in the detection of active lesions in multiple sclerosis: a longitudinal study [abstract]. J Neurol 1997;244(suppl 3):S74.
18. Filippi M, Yousry T, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast-fluid-attenuated inversion recovery. Brain 1996;119:1349-55.
19. Rydberg JN, Hammond CA, Grimm RC, et al. Initial experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994;93:173-80.
20. Hashemi RH, Bradley WG, Chen DY, et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology 1995;196:505-10.
21. Stevenson VL, Gawne-Cain ML, Barker GJ, et al. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo. J Neurol 1997;244:119-24.
22. Gawne-Cain ML, O'Riordan JI, Thompson AJ, et al. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin echo. Neurology 1997;49:364-70.
23. Siewert B, Patel MR, Mueller MF, et al. Brain lesions in patients with multiple sclerosis: detection with echo-planar imaging. Radiology 1995;196:765-71.
24. Rovaris M, Yousry TA, Calori G, et al. Sensitivity and reproducibility of fast-FLAIR, FSE, and TGSE sequences for the MRI assessment of brain lesion load in multiple sclerosis: a preliminary study. J Neuroimaging 1997;7:98-102.
25. Rovaris M, Gawne-Cain ML, Wang L, et al. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semiautomated contouring technique. Neuroradiology 1997;39:161-5.
26. Filippi M, Yousry TA, Alkadhi H, et al. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. J Neurol Neurosurg Psychiatry 1996;61:632-5.
27. Keiper MD, Grossman RI, Brunson JC, et al. The low sensitivity of fluid attenuated inversion recovery (FLAIR) imaging in the detection of multiple sclerosis of the spinal cord. AJNR Am J Neuroradiol 1997;18:1035-9.
28. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS. Brain 1993;116:1077-94.
29. Lai M, Hodgson T, Gawne-Cain M, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:339-41.
30. Filippi M, Yousry T, Rocca MA, et al. Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis. Acta Neurol Scand 1997;95:331-4.
31. Thorpe JW, Kidd D, Moseley IF, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 1996; 46:373-8.
32. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996;46:379-84.
33. Filippi M, Barkhof F, Bressi S, et al. Inter-rater variability in reporting enhancing lesions on standard and triple dose gadolinium scans in patients with multiple sclerosis. Multiple Sclerosis 1997(in press).
34. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60: 526-30.
35. Silver NC, Good CD, Barker GJ, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetisation transfer contrast and delayed imaging. Brain 1997;120:1149-61.
36. Filippi M, Rovaris M, Capra R, et al. A multicentre longitudinal study comparing the sensitivity of enhanced brain MRI after the injection of standard and triple dose gadolinium-DTPA for detecting active lesions in MS [abstract]. Neurology 1997;48(suppl):A362.
37. Filippi M, Campi A, Martinelli V, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:540-4.
38. Metha RC, Pike BG, Enzmann DR. Improved detection of enhancing and non-enhancing lesions of multiple sclerosis with magnetization transfer. AJNR Am J Neuroradiol 1995;16:1771-8.
39. van Waesberghe JHTM, Castelijns JA, Roser W, et al. Single dose gadolinium with magnetization transfer contrast versus triple dose gadolinium in detecting enhancing multiple sclerosis lesions. AJNR Am J Neuroradiol 1997;18:1279-85.
40. Gasperini C, Bastianello S, Pozzilli C, et al. A multicentre study comparing the sensitivity of T1-weighted images with and without magnetization transfer after the injection of standard and triple dose of gadolinium in detecting enhancing lesions in MS [abstract]. J Neurol 1997;244(suppl 3):S24.
41. Filippi M, Yousry T, Horsfield MA, et al. A high-resolution three-dimensional gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996;40:901-7.
42. Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-54.
43. Filippi M, Marcianò N, Capra R, et al. The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology 1997;49: 274-6.
44. Filippi M, van Waesberghe JH, Horsfield MA, et al. Interscanner variation in brain MRI lesion load measurements in multiple sclerosis: implications for clinical trials. Neurology 1997;49:371-2.
45. Filippi M, Horsfield MA, Rovaris M, et al. Intra- and inter-observer variability of brain MRI lesion volume estimation schemes in multiple sclerosis. AJNR Am J Neuroradiol 1997;49:371-7.
46. Tubridy N, Barker GJ, MacManus D, et al. Optimisation of non-enhanced magnetic resonance imaging for the detection of lesions in multiple sclerosis: a pilot study to compare five MRI sequences. Neuroradiology 1998 (in press).
47. Campi A, Filippi M, Comi G, et al. Magnetization transfer ratios of enhancing and non-enhancing lesions in multiple sclerosis. Neuroradiology 1996;38:115-9.
48. Hiehle JF, Grossman RI, Ramer NK, et al. Magnetization transfer effect in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and non-enhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77.
49. Filippi M, Rocca MA, Rovaris M, et al. A comparison of the magnetization transfer ratio of multiple sclerosis lesions enhancing after the injection of a standard or a triple dose of gadolinium-DTPA [abstract]. J Neurol 1997;244(suppl 3):S74-5.
50. Tievsky AL, Ptak T, Wu O, et al. Evaluation of MS lesions with full tensor diffusion weighted imaging and anisotropy mapping [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997; 1:666.
51. Gass A, Gaa J, Schreiber W, et al. Echo planar diffusion weighted magnetic resonance imaging in patients with active multiple sclerosis [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:658.
52. Grossman RI, Lenkinski RE, Ramer NK, et al. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535-43.
53. Dousset V, Brochet B, Gayou A, et al. Magnetization transfer profile of demyelinating CNS lesions [abstract]. Proceedings of the Society for Magnetic Resonance in Medicine 1995;1:114.
54. Rooney W, Goodkin D, Vermathen M, et al. Temporal relationship between Gd enhancement and reduced MTR in MS lesions [abstract]. Neurology 1997;48 (Suppl):A311.
55. Alonso J, Rovira A, Cucurella MG, et al. Serial magnetization transfer imaging in multiple sclerosis lesions [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:639.
56. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
57. van Waesberghe JHTM, van Walderveen MAA, Casteljins JA, et al. Natural history of T1 black holes in new enhancing multiple sclerosis lesions [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:644.
58. Rombouts SARB, Barkhof F, Uitdehaag BMJ, et al. FMRI of the visual cortex: a pilot study on activation patterns of patients with optic neuritis using monocular stimulation [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:516.
59. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-7.
60. Filippi M, Barker GJ, Horsfield MA, et al. Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 1994;241:246-51.
61. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996;119:715-22.
62. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996;119:2009-19.
63. Filippi M, Campi A, Colombo B, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996;243:502-5.
64. Filippi M, Colombo B, Rovaris M, et al. A longitudinal magnetic resonance imaging study of the cervical cord in multiple sclerosis. J Neuroimaging 1997;7:78-80.
65. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701-8.
66. 1-weighted) spin-echo images. Neurology 1995;45:1684-90.
67. van Waesberghe JHTM, Casteljins JA, Scheltens P, et al. Comparison of four potential MR parameters for severe tissue distraction in multiple sclerosis lesions. Magn Reson Imaging 1997;15:155-62.
68. 1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995;16:1473-9.
69. 1weighted SE MR images correlate with axonal loss in multiple sclerosis [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:75.
70. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (black holes) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-76.
71. De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-9.
72. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 1995;118:1583-92.
73. Thorpe JW, Barker GJ, Jones SJ, et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995;58: 487-92.
74. Iwasawa T, Matoba H, Kurihara H, et al. Diffusion-weighted imaging of human optic nerve: a new approach to the optic neuritis due to multiple sclerosis [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:668.
75. Lyklama à Nijeholt GJ, van Waesberghe JHTM, Barkhof F, et al. Decrease of magnetization transfer ratio in the cervical cord of multiple sclerosis patients: clinical relevance and relation to atrophy [abstract]. Proceedings of the International Society for Magnetic Resonance in Medicine 1997;1:426.
76. Barbosa S, Blumhardt LD, Roberts N, et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the invisible lesion load. Magn Reson Imaging 1994;12:33-42.
77. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-82.
78. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiolos, 1995;96:511-5.
79. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-91.
80. Davies SEC, Newcombe J, Williams SR, et al. High resolution proton NMR spectrocopy of multiple sclerosis lesions. J Neurochem 1995;64:742-8.
81. Roser W, Hagberg G, Mader I, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995;33:811-7.